New molecular markers for prostate tumor imaging: a study on 2-methylene 
substituted fatty acids as new AMACR inhibitors

Morgenroth, Agnieszka; Urusova, Elizaveta A.; Dinger, Cornelia; Al-Momani, Ehab; Kull, Thomas; Glatting, Gerhard; Frauendorf, Holm; Jahn, Olaf; Mottaghy, Felix M.; Reske, Sven N.; Zlatopolskiy, Boris D.

doi:10.1002/chem.201003176

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors

MPS-Authors

/persons/resource/persons182214

Jahn, Olaf
Proteomics, Wiss. Servicegruppen, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Morgenroth, A., Urusova, E. A., Dinger, C., Al-Momani, E., Kull, T., Glatting, G., et al. (2011). New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors. Chemistry - A European Journal, 17, 10144-10150. doi:10.1002/chem.201003176.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-34E3-D

Abstract

There is no abstract available